Caravel Bio advanced a microfluidic platform for protein engineering that couples cell-free synthesis in microdroplets with a bacterial spore-based display concept. The approach targets industrial scaling bottlenecks by enabling earlier, larger-scale design-build-test cycles under real-world conditions, aiming to accelerate selection of functional enzymes and proteins.